Preprint / Version 1

Nanoparticle-Based Cancer Therapeutics: From Synthesis to Clinical Applications

##article.authors##

  • Giselle Chan Mark Keppel High School

DOI:

https://doi.org/10.58445/rars.4249

Keywords:

Nanoparticles in Cancer Therapy, Biological Synthesis of Nanoparticles, Green Synthesis

Abstract

Nanoparticles are increasingly popular for cancer treatment. They can be modified to researchers’ needs, whether that’s shape, size, or functionalization, to target a specific cell or travel to a certain area in the body. Synthesis methods vary, and include chemical and biological synthesis. Traditional chemical synthesis methods can produce toxic chemicals, so more eco-friendly techniques have been developed. Biological synthesis is more safe and eco-friendly as it uses microorganisms to make the metallic materials needed to synthesize nanoparticles. Two types of biologically synthesized nanoparticles will be discussed: metallic and polymeric. Although metallic and polymeric nanoparticles are not only synthesized through biological synthesis, this paper will touch specifically upon biological synthesis methods. Nanoparticles are being used to detect and identify cancer cells, predict how a cancer will advance, and to treat cancer. In cancer diagnosis, nanoparticles are used as contrasting agents for imaging and as biomarkers. This paper will also discuss how nanoparticles are being used in treatment techniques, specifically chemotherapeutics, immunotherapy, and radiation therapy. In chemotherapeutics, nanoparticles store the chemotherapeutic drug and release it into targeted cancer cells. Nanoparticles are also used in immunotherapy by increasing the stimulation of innate immune cells. In radiation therapy, nanoparticles can better localize treatment so that healthy cells are less affected. Our knowledge of the abilities and limitations of nanoparticles in cancer therapy has expanded significantly and is expected to continue to grow. In the future, cancer treatment technology may evolve to use hydrogel-embedded nanoparticles, potentially enhancing the controlled delivery of cancer treatments.

References

Horikoshi, S., & Serpone, N. (2013). Introduction to Nanoparticles. In Microwaves in Nanoparticle Synthesis (pp. 1–24). Wiley. https://doi.org/10.1002/9783527648122.ch1

Mirmohammadi, S. V., Zolfaghari, B., Korbekandi, H., & Iravani, S. (2014). Synthesis of silver nanoparticles: chemical, physical and biological methods. Research in Pharmaceutical Sciences, 9(6), 385–406.

David D. Evanoff, George Chumanov; Size-Controlled Synthesis of Nanoparticles. 2. Measurement of Extinction, Scattering, and Absorption Cross Sections. J. Phys. Chem. B 16 September 2004; 108 (37): 13957–13962. https://doi.org/10.1021/jp0475640

Getahun Merga, Robert Wilson, Geoffrey Lynn, Bratoljub H. Milosavljevic, Dan Meisel; Redox Catalysis on “Naked” Silver Nanoparticles. J. Phys. Chem. C 23 August 2007; 111 (33): 12220–12226. https://doi.org/10.1021/jp074257w

Pantidos, N. (2014). Biological Synthesis of Metallic Nanoparticles by Bacteria, Fungi and Plants. Journal of Nanomedicine & Nanotechnology, 05(05). https://doi.org/10.4172/2157-7439.1000233

Prathamesh R. Sune, Kajal S. Jumde, Pooja R. Hatwar, Ravindra L. Bakal, Samiksha D. More, & Atharv V. Korde. (2024). Nanoparticles: Classification, types and applications: A comprehensive review. GSC Biological and Pharmaceutical Sciences.

Xu, J.-J., Zhang, W.-C., Guo, Y.-W., Chen, X.-Y., & Zhang, Y.-N. (2022). Metal nanoparticles as a promising technology in targeted cancer treatment. Drug Delivery, 29(1), 664–678. https://doi.org/10.1080/10717544.2022.2039804

Behranvand, N., Nasri, F., Zolfaghari Emameh, R., Khani, P., Hosseini, A., Garssen, J., & Falak, R. (2022). Correction to: Chemotherapy: a double‑edged sword in cancer treatment. Cancer Immunology, Immunotherapy, 71(3), 527–527. https://doi.org/10.1007/s00262-021-03034-y

WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007). Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆. Advanced Drug Delivery Reviews, 59(6), 491–504. https://doi.org/10.1016/j.addr.2007.04.008

Pajor-Świerzy, A., Szczepanowicz, K., Kamyshny, A., & Magdassi, S. (2022). Metallic core-shell nanoparticles for conductive coatings and printing. Advances in Colloid and Interface Science, 299, 102578. https://doi.org/10.1016/j.cis.2021.102578

Nomoev, A. v, Bardakhanov, S. P., Schreiber, M., Bazarova, D. G., Romanov, N. A., Baldanov, B. B., Radnaev, B. R., & Syzrantsev, V. v. (2015). Structure and mechanism of the formation of core–shell nanoparticles obtained through a one-step gas-phase synthesis by electron beam evaporation. Beilstein Journal of Nanotechnology, 6, 874–880. https://doi.org/10.3762/bjnano.6.89

Cardoso, B., Nobrega, G., Afonso, I. S., Ribeiro, J. E., & Lima, R. A. (2025). Sustainable green synthesis of metallic nanoparticle using plants and microorganisms: A review of biosynthesis methods, mechanisms, toxicity, and applications. Journal of Environmental Chemical Engineering, 13(3), 116921. https://doi.org/10.1016/j.jece.2025.116921

Xu, Z., Feng, Q., Wang, M., Zhao, H., Lin, Y., & Zhou, S. (2020). Green Biosynthesized Silver Nanoparticles With Aqueous Extracts of Ginkgo Biloba Induce Apoptosis via Mitochondrial Pathway in Cervical Cancer Cells. Frontiers in Oncology, 10. https://doi.org/10.3389/fonc.2020.575415

Alshameri, A. W., & Owais, M. (2022). Antibacterial and cytotoxic potency of the plant-mediated synthesis of metallic nanoparticles Ag NPs and ZnO NPs: A review. OpenNano, 8, 100077. https://doi.org/10.1016/j.onano.2022.100077

Deka, K., Nongbet, R. D., Das, K., Saikia, P., Kaur, S., Talukder, A., & Thakuria, B. (2025). Understanding the mechanism underlying the green synthesis of metallic nanoparticles using plant extract(s) with special reference to Silver, Gold, Copper and Zinc oxide nanoparticles. Hybrid Advances, 9, 100399. https://doi.org/10.1016/j.hybadv.2025.100399

Patra, N., Kar, D., Pal, A., & Behera, A. (2018). Antibacterial, anticancer, anti-diabetic and catalytic activity of bio-conjugated metal nanoparticles. Advances in Natural Sciences: Nanoscience and Nanotechnology, 9(3), 035001. https://doi.org/10.1088/2043-6254/aad12d

Austria, E., Bilek, M., Varamini, P., & Akhavan, B. (2025). Breaking biological barriers: Engineering polymeric nanoparticles for cancer therapy. Nano Today, 60, 102552. https://doi.org/10.1016/j.nantod.2024.102552

Jiwei Cui, Robert De Rose, Karen Alt, Sheilajen Alcantara, Brett M. Paterson, Kang Liang, Ming Hu, Joseph J. Richardson, Yan Yan, Charmaine M. Jeffery, Roger I. Price, Karlheinz Peter, Christoph E. Hagemeyer, Paul S. Donnelly, Stephen J. Kent, Frank Caruso; Engineering Poly(ethylene glycol) Particles for Improved Biodistribution. ACS Nano 24 February 2015; 9 (2): 1571–1580. https://doi.org/10.1021/nn5061578

Zambaux, M. (1998). Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. Journal of Controlled Release, 50(1–3), 31–40. https://doi.org/10.1016/S0168-3659(97)00106-5

Suffredini, G., East, J. E., & Levy, L. M. (2014). New Applications of Nanotechnology for Neuroimaging. American Journal of Neuroradiology, 35(7), 1246–1253. https://doi.org/10.3174/ajnr.A3543

Pulingam, T., Foroozandeh, P., Chuah, J.-A., & Sudesh, K. (2022). Exploring Various Techniques for the Chemical and Biological Synthesis of Polymeric Nanoparticles. Nanomaterials (Basel, Switzerland), 12(3). https://doi.org/10.3390/nano12030576

Singh, R., & Lillard, J. W. (2009). Nanoparticle-based targeted drug delivery. Experimental and Molecular Pathology, 86(3), 215–223. https://doi.org/10.1016/j.yexmp.2008.12.004

Remya, R. R., Julius, A., Suman, T. Y., Mohanavel, V., Karthick, A., Pazhanimuthu, C., Samrot, A. v., & Muhibbullah, M. (2022). Role of Nanoparticles in Biodegradation and Their Importance in Environmental and Biomedical Applications. Journal of Nanomaterials, 2022(1). https://doi.org/10.1155/2022/6090846

Lee, J. H., & Yeo, Y. (2015). Controlled drug release from pharmaceutical nanocarriers. Chemical Engineering Science, 125, 75–84. https://doi.org/10.1016/j.ces.2014.08.046

Burkersroda, F. von, Schedl, L., & Göpferich, A. (2002). Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials, 23(21), 4221–4231. https://doi.org/10.1016/S0142-9612(02)00170-9

Jingchao Li, Hongli Mao, Naoki Kawazoe, Guoping Chen; Insight into the interactions between nanoparticles and cells. Biomater. Sci. 2017; 5 (2): 173–189. https://doi.org/10.1039/c6bm00714g

Hühn, D., Kantner, K., Geidel, C., Brandholt, S., de Cock, I., Soenen, S. J. H., Rivera_Gil, P., Montenegro, J.-M., Braeckmans, K., Müllen, K., Nienhaus, G. U., Klapper, M., & Parak, W. J. (2013). Polymer-Coated Nanoparticles Interacting with Proteins and Cells: Focusing on the Sign of the Net Charge. ACS Nano, 7(4), 3253–3263. https://doi.org/10.1021/nn3059295

Schleh, C., Semmler-Behnke, M., Lipka, J., Wenk, A., Hirn, S., Schäffler, M., Schmid, G., Simon, U., & Kreyling, W. G. (2012). Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology, 6(1), 36–46. https://doi.org/10.3109/17435390.2011.552811

Xiao, B., Han, M. K., Viennois, E., Wang, L., Zhang, M., Si, X., & Merlin, D. (2015). Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy. Nanoscale, 7(42), 17745–17755. https://doi.org/10.1039/C5NR04831A

Machado, V., Morais, M., & Medeiros, R. (2022). Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now? Pharmaceutics, 14(10). https://doi.org/10.3390/pharmaceutics14102092

Almoustafa, H. A., Alshawsh, M. A., Al-Suede, F. S. R., Alshehade, S. A., Abdul Majid, A. M. S., & Chik, Z. (2023). The Chemotherapeutic Efficacy of Hyaluronic Acid Coated Polymeric Nanoparticles against Breast Cancer Metastasis in Female NCr-Nu/Nu Nude Mice. Polymers, 15(2), 284. https://doi.org/10.3390/polym15020284

FitzGerald, T.J., Bishop-Jodoin, M., Laurie, F., Riberdy, C., Aronowitz, J.N., Bannon, E., Bornstein, B.A., Bradford, C.D., Bushe, H., Cicchetti, M.G., Ding, L., Glanzman, J.M., Goff, D.J., Herrick, B.B., Hiatt, J.R., Kuo, I.-L., Lo, Y.-C., Moni, J., Pieters, R.S., Rava, P.S., Sacher, A., Saleeby, J., Sioshansi, S., Ulin, K., Varlotto, J.M. and Wang, T. (2019). RADIATION THERAPY. In Cancer (eds G.S. Stein and K.P. Luebbers). https://doi.org/10.1002/9781119645214.ch24

Retif, P., Pinel, S., Toussaint, M., Frochot, C., Chouikrat, R., Bastogne, T., & Barberi-Heyob, M. (2015). Nanoparticles for Radiation Therapy Enhancement: the Key Parameters. Theranostics, 5(9), 1030–1044. https://doi.org/10.7150/thno.11642

Carter, J. D., Cheng, N. N., Qu, Y., Suarez, G. D., & Guo, T. (2007). Nanoscale Energy Deposition by X-ray Absorbing Nanostructures. The Journal of Physical Chemistry B, 111(40), 11622–11625. https://doi.org/10.1021/jp075253u

Park, Y.-S., Liz-Marzán, L. M., Kasuya, A., Kobayashi, Y., Nagao, D., Konno, M., Mamykin, S., Dmytruk, A., Takeda, M., & Ohuchi, N. (2006). X-ray absorption of gold nanoparticles with thin silica shell. Journal of Nanoscience and Nanotechnology, 6(11), 3503–3506.

Wardman, P. (2007). Chemical Radiosensitizers for Use in Radiotherapy. Clinical Oncology, 19(6), 397–417. https://doi.org/10.1016/j.clon.2007.03.010

Chen, Y., Yang, J., Fu, S., & Wu, J. (2020).

Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy

. International Journal of Nanomedicine, Volume 15, 9407–9430. https://doi.org/10.2147/IJN.S272902

Her, S., Jaffray, D. A., & Allen, C. (2017). Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements. Advanced Drug Delivery Reviews, 109, 84–101. https://doi.org/10.1016/j.addr.2015.12.012

Afifi, M. M., El-Gebaly, R. H., Abdelrahman, I. Y., & Rageh, M. M. (2023). Efficacy of iron-silver bimetallic nanoparticles to enhance radiotherapy. Naunyn-Schmiedeberg’s Archives of Pharmacology, 396(12), 3647–3657. https://doi.org/10.1007/s00210-023-02556-9

Zhang, X., Liu, Z., Lou, Z., Chen, F., Chang, S., Miao, Y., … Zhang, H. (2018). Radiosensitivity enhancement of Fe3O4@Ag nanoparticles on human glioblastoma cells. Artificial Cells, Nanomedicine, and Biotechnology, 46(sup1), 975–984. https://doi.org/10.1080/21691401.2018.1439843

Yang, L., Ning, Q., & Tang, S. (2022). Recent Advances and Next Breakthrough in Immunotherapy for Cancer Treatment. Journal of Immunology Research, 2022, 1–9. https://doi.org/10.1155/2022/8052212

Kun Shao, Santiswarup Singha, Xavier Clemente-Casares, Sue Tsai, Yang Yang, Pere Santamaria; Nanoparticle-Based Immunotherapy for Cancer. ACS Nano 27 January 2015; 9 (1): 16–30. https://doi.org/10.1021/nn5062029

Park, W., Heo, Y.-J., & Han, D. K. (2018). New opportunities for nanoparticles in cancer immunotherapy. Biomaterials Research, 22(1). https://doi.org/10.1186/s40824-018-0133-y

Yusuf, A., Almotairy, A. R. Z., Henidi, H., Alshehri, O. Y., & Aldughaim, M. S. (2023). Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems. Polymers, 15(7), 1596. https://doi.org/10.3390/polym15071596

Fransen, M. F., Sluijter, M., Morreau, H., Arens, R., & Melief, C. J. M. (2011). Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody. Clinical Cancer Research, 17(8), 2270–2280. https://doi.org/10.1158/1078-0432.CCR-10-2888

Sandin, L. C., Orlova, A., Gustafsson, E., Ellmark, P., Tolmachev, V., Tötterman, T. H., & Mangsbo, S. M. (2014). Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer. Cancer Immunology Research, 2(1), 80–90. https://doi.org/10.1158/2326-6066.CIR-13-0067

Downloads

Posted

2026-10-11